Deferoxamine Mesylate 00409-2337-25
- Manufacturer
- Hospira, Inc.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intramuscular, Intravenous, And Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- March 31, 2005
- Listing Expires
- December 31, 2027
- Application
- ANDA076019
Need to source Deferoxamine Mesylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Deferoxamine Mesylate | 2 g/1 |
Drug Class
Iron Chelating Activity [MoA]Iron Chelator [EPC]
Selected Package
00409-2337-25Selected4 VIAL, SINGLE-USE in 1 CARTON (0409-2337-25) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (0409-2337-15)